Susan Hasty, Publisher
Table of Contents . . . April 29th, 1996Non-Subscriber - Summaries Only
Animal Models (Gene Therapy) - Model Proves that Transduced Hematopoietic Stem Cells Differentiate In Vivo
Antisense Technology - Proprietary Permeation Enhancers To Deliver Genetic Code Blockers Discovered
Cancer Gene Therapy - Aerosolized Administration of Lipid-p53 Gene Complexes Stops Lung Cancer
Cancer Gene Therapy - Innovative Drug Strategies Show Promise
Cancer Gene Therapy - Trials Begin for Anticancer Agent Onyx-015
Cancer Gene Therapy - Wild-Type p53 Expression Reduces Tumorigenicity in a Variety of Cancers
Conference Coverage (IBC Vaccines) - Genentech Shoots for Single-Shot gp120 AIDS Vaccine
HIV Gene Therapy - Prolonging CD4+ T Cell Survival in HIV Patients
Immunology - New Data Support Danger Model of Immunity
Industry News (Funding) - NIH Grant Awarded for DNA Detection
Industry News (Patents and Technology) - Three U.S. Human Gene Patents Issued
Ovarian Cancer (Genetics) - Epidemiology of Cancer Related to BRCA1 Gene
Vaccine Development - Poliovirus Pathogenicity Abolished by Rhinovirus Gene Insert
Cancer Vaccines (Melanoma) - "Pre-Immunization of Mice with Irradiated B16-F10 Melanoma Cells Transfected to Secrete GM-CSF Coupled with GM-CSF Therapy Gave Superior Protection to Tumor Challenge Compared to Similar Treatment with Irra
Immunotherapy (Cancer) - "Therapy of Murine Tumors with p53 Wild Type Sequence Peptide-Based Vaccine."
Hammerhead Ribozymes - "Designing of Chimeric DNA/RNA Hammerhead Ribozymes to be Targeted Against AML1/MTG8 mRNA."
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.